Home  |   Publications  |   Ebooks  |   Conferences  |   Articles  |   Track Your Manuscript  |   Signin/Signup

Andrew Hague


Andrew Hague’s great interest in the technology that was to become CellSonic began in 1987 with the first lithotripter in Britain. Using his own capital, he developed the CellSonic VIPP machines and sold them around the world.

In 2016, Professor Hague devised the protocol for curing cancer and this is now used in CellSonic Clinics in India, Peru, Switzerland and Poland. Many more are planned. There are no side effects, drugs must not be used and the cancer is stopped within three days.

CellSonic VIPP has been used for physiotherapy and sports medicine for twenty years. Where the patient also had cut skin, the cure for non-healing wounds was discovered and that led to repairing nerves and pain relief.

Professor Hague is the owner of CellSonic Limited and advises the Universities of Bradford in England and Hyderabad in India.

Research Interests:

  • Tissue regeneration
  • Cancer - diagnosis and treatment
  • Diabetes - reversal
  • Alzheimer’s disease
  • Parkinson’s disease

Open Access Journals

Subscribe to our Newsletter

Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.


We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.

Do you have an idea or suggestion that can influence the Open Access community? Send an email to:

Recently Released Issues